Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-14

Clinical Trial Update: Unique Effects of Perimenstrual Estradiol or Progesterone Supplementation on Perimenstrual Suicidality [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating perimenstrual estradiol or progesterone supplementation and its unique effects on perimenstrual suicidality; results completed with pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • perimenstrual estradiol (estradiol)
  • perimenstrual progesterone (progesterone)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Suicidal Ideation | Phase 4 | Status: COMPLETED | Results posted: 2022-09-14